全球颈动脉支架市场规模、份额、趋势和成长分析报告（2026-2034年）

预计颈动脉支架市场将从 2025 年的 6.6464 亿美元成长到 2034 年的 9.1057 亿美元，2026 年至 2034 年的复合年增长率为 3.56%。

随着全球心血管疾病和中风发病率的上升，全球颈动脉支架市场正稳定成长。颈动脉置入术是一种微创手术，用于治疗颈动脉狭窄和预防中风。人们对微创手术技术的日益青睐以及患者预后的改善推动了该技术的普及。支架设计和影像导引系统的技术进步进一步提高了手术的安全性和有效性。

人口老化、久坐的生活方式以及高血压和高胆固醇盛行率的上升是推动心血管疾病成长的成长要素。医疗机构正着重强调早期诊断和预防性心血管治疗。生物相容性材料和栓塞预防装置的改进正在提升临床疗效。此外，已开发国家医疗基础设施的扩建和医疗政策的完善也促进了先进支架置入术的应用。

展望未来，得益于新一代药物释放型支架的创新和导管系统的改进，预计市场将保持强劲成长。在新兴市场，随着人们对心臟疾病的认识不断提高以及心臟治疗设施的扩建，预计将迎来成长机会。正在进行的临床试验和先进医疗设备的监管核准将进一步刺激市场需求。由于预防中风仍然是医疗保健的重中之重，颈动脉支架市场预计将继续保持其全球持续成长的势头。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球颈动脉支架市场：依类型划分

• 市场分析、洞察与预测
• 药物释放型支架
• 裸金属支架
• 生物可吸收支架

第五章 全球颈动脉支架市场：依材料划分

• 市场分析、洞察与预测
• 金属
• 聚合物

第六章：全球颈动脉支架市场：依输送方式划分

• 市场分析、洞察与预测
• 球囊扩张型支架
• 自动扩张型支架

第七章 全球颈动脉支架市场：依最终用途划分

• 市场分析、洞察与预测
• 医院
• 门诊手术中心
• 其他的

第八章 全球颈动脉支架市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Abbott Laboratories Inc
  • Balton Sp Z OO
  • Boston Scientific Corporation
  • Cordis
  • InspireMD Inc
  • Medtronic Plc
  • Terumo Europe NV
  • MicroPort Scientific Corporation
  • Silk Road Medical Inc
  • Cardinal Health Inc

The Carotid Artery Stents Market size is expected to reach USD 910.57 Million in 2034 from USD 664.64 Million (2025) growing at a CAGR of 3.56% during 2026-2034.

The Global Carotid Artery Stents Market is growing steadily due to the rising incidence of cardiovascular diseases and stroke worldwide. Carotid artery stenting is a minimally invasive procedure used to prevent stroke by treating carotid artery stenosis. Increasing preference for minimally invasive surgical techniques and improved patient outcomes are driving adoption. Technological advancements in stent design and imaging guidance systems further enhance procedural safety and effectiveness.

Key growth drivers include aging populations, sedentary lifestyles, and increasing hypertension and cholesterol levels. Healthcare providers are emphasizing early diagnosis and preventive cardiovascular treatments. Improvements in biocompatible materials and embolic protection devices have strengthened clinical outcomes. Additionally, expanding healthcare infrastructure and reimbursement policies in developed economies are supporting the adoption of advanced stenting procedures.

Future prospects indicate strong growth with innovation in next-generation drug-eluting stents and improved catheter systems. Emerging markets are expected to offer growth opportunities due to rising awareness and expanding cardiac care facilities. Continuous clinical research and regulatory approvals for advanced devices will further stimulate demand. As stroke prevention remains a healthcare priority, the carotid artery stents market is likely to experience sustained global expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Drug Eluting Stents
• Bare Metal Stents
• Bioabsorbable Stents

By Material

• Metals
• Polymers

By Mode of Delivery

• Balloon-expandable Stents
• Self-expanding Stents

By End-use

• Hospitals
• Ambulatory Surgical Centers
• Others

COMPANIES PROFILED

• Abbott Laboratories Inc, Balton Sp z oo, Boston Scientific Corporation, Cordis, InspireMD Inc, Medtronic plc, Terumo Europe NV, MicroPort Scientific Corporation, Silk Road Medical Inc, Cardinal Health Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CAROTID ARTERY STENTS MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Drug Eluting Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Bare Metal Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Bioabsorbable Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CAROTID ARTERY STENTS MARKET: BY MATERIAL 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Material
• 5.2. Metals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Polymers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CAROTID ARTERY STENTS MARKET: BY MODE OF DELIVERY 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Mode Of Delivery
• 6.2. Balloon-expandable Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Self-expanding Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CAROTID ARTERY STENTS MARKET: BY END-USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-use
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL CAROTID ARTERY STENTS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Type
  • 8.2.2 By Material
  • 8.2.3 By Mode Of Delivery
  • 8.2.4 By End-use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Type
  • 8.3.2 By Material
  • 8.3.3 By Mode Of Delivery
  • 8.3.4 By End-use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Type
  • 8.4.2 By Material
  • 8.4.3 By Mode Of Delivery
  • 8.4.4 By End-use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Type
  • 8.5.2 By Material
  • 8.5.3 By Mode Of Delivery
  • 8.5.4 By End-use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Type
  • 8.6.2 By Material
  • 8.6.3 By Mode Of Delivery
  • 8.6.4 By End-use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL CAROTID ARTERY STENTS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Abbott Laboratories Inc
  • 10.2.2 Balton Sp Z O.O
  • 10.2.3 Boston Scientific Corporation
  • 10.2.4 Cordis
  • 10.2.5 InspireMD Inc
  • 10.2.6 Medtronic Plc
  • 10.2.7 Terumo Europe NV
  • 10.2.8 MicroPort Scientific Corporation
  • 10.2.9 Silk Road Medical Inc
  • 10.2.10 Cardinal Health Inc